“Role of intranasal midazolam as a procedural sedative in children aged 6 months to 12 years: An open-label randomized controlled study” (2018) Indian Journal of Child Health, 5(1), pp. 1–5. doi:10.32677/IJCH.2018.v05.i01.001.